merck glp-1 agonist Partners with Hansoh Pharma on Oral Receptor for Type 2 Diabetes GLP-1 agonists in the treatment

Exploring GLP-1 treatment

[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Prez E, Martnez-Tadeo J, Callero A, Hernndez G, Rodrguez-Plata E, Garca-Robaina JC

North American region is leading the GLP-1 agonists market.

Besides making insulin, the pancreas makes various digestive enzymes that allow us to digest food, and delivers those enzymes to the intestinal tract via a series of channels

and ameliorated glucose tolerance through increasing the insulin secretion multiple by 51.3% after 15 min of glucose stimulation ( p = 0.07) (14)

Prior authorization and step therapy protocols, as well as body mass index and medical conditions-based criteria, remain some of the major factors affecting patients access to reimbursement